Condition

Solid Carcinoma clinical trials and research

• 13Clinical trials
• 11Countries

Newest Solid Carcinoma clinical trials

All recruiting trials (13)

• Imaging with 89Zr-DFO-YS5 to detect cancer

  This study tests a new PET radiotracer, 89Zr-DFO-YS5, to see if it can show cancer sites in adults with nerve sheath tumors, bladder cancer, or other solid tumors.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT07664397

• MSK-TCR5 in adults with advanced solid tumors that have KRAS/HRAS/NRAS G12D

  This study tests MSK-TCR5 to see if it is safe for adults with advanced solid tumors carrying a KRAS, HRAS, or NRAS G12D mutation.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07638371

• Using 18F-TRX to image solid tumors

  This trial tests whether the 18F-TRX PET tracer can detect tumors in adults with advanced solid tumors such as high‑grade glioma, clear cell renal cell carcinoma, or metastatic castration‑resistant prostate cancer.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT06942104

• PET imaging with [89Zr]DFO-starPEG for solid tumors

  We will test a new PET imaging tracer called [89Zr]DFO-starPEG in adults with measurable solid tumors to see if it highlights tumor uptake and is safe.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT06894745

• ImmunoPET imaging for solid tumors targeting Trop2

  This study is testing a new imaging method to see if it can help diagnose solid tumors like bladder and prostate cancer better than current methods.

  Recruiting Phase 2/3 RenJi Hospital · Shanghai · NCT06851663

• Testing DM002 in patients with advanced solid tumors

  This study is testing a new drug called DM002 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 7 sites Phase 1/2 Doma Biopharmaceutical（Suzhou）Co., Ltd. · San Francisco, California and 6 other locations · NCT06751329

• Testing DM005 for advanced solid tumors

  This study is testing a new treatment called DM005 to see if it can help people with advanced solid tumors feel better and improve their health.

  Recruiting at 6 sites Phase 1/2 Doma Biopharmaceutical（Suzhou）Co., Ltd. · Detroit, Michigan and 5 other locations · NCT06515990

• Predicting blood clot risks in cancer patients

  This study is testing if measuring certain blood factors can help predict blood clot risks in cancer patients who are at high risk for complications during treatment.

  Recruiting Institut Cancerologie de l'Ouest · Saint-Herblain · NCT06051214

• Platform program for evaluating treatments in metastatic HER2-positive breast cancer

  This study is testing different new treatments for people with advanced HER2-positive breast cancer to see which ones work best before moving them to larger trials.

  Recruiting at 5 sites Phase 1/2 QuantumLeap Healthcare Collaborative · Birmingham, Alabama and 9 other locations · NCT05868226

• Evaluating BDTX-4933 for patients with specific cancer mutations

  This study is testing a new drug called BDTX-4933 to see if it can help adults with advanced cancers that have certain gene mutations feel better and improve their treatment options.

  Recruiting at 34 sites Phase 1/2 Servier · Gilbert, Arizona and 48 other locations · NCT05786924

• Fecal transplant plus nivolumab for people with advanced solid cancers that progressed on anti-PD-(L)1 therapy

  This will try a donor-derived fecal microbiota transplant together with nivolumab to see if it can control disease in people with advanced solid tumors who progressed on anti-PD-(L)1 drugs.

  Recruiting Asan Medical Center · Seoul · NCT05533983

• INV-1120 alone and with pembrolizumab for adults with advanced solid tumors

  This Phase 1 study will test whether the experimental drug INV-1120, given alone or with pembrolizumab, is safe and tolerable in adults with advanced solid tumors who have progressed after standard therapies.

  Recruiting Phase 1 Shenzhen Ionova Life Sciences Co., Ltd. · Lafayette, Indiana and 2 other locations · NCT04443088

• Microbiome biomarkers and fecal microbiota transplantation to support immunotherapy in solid tumors

  This trial tests whether the gut microbiome can help guide immunotherapy and whether fecal microbiota transplantation can boost immunotherapy in adults with solid cancers.

  Recruiting Asan Medical Center · Seoul, Seoul · NCT04264975

Related topics

Quick answers

How many Solid Carcinoma clinical trials are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United States (9 trials), Australia (3 trials), China (2 trials), France (2 trials), South Korea (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 5, Phase 1/2: 4, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →